0001209191-24-002079.txt : 20240123 0001209191-24-002079.hdr.sgml : 20240123 20240123170043 ACCESSION NUMBER: 0001209191-24-002079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240121 FILED AS OF DATE: 20240123 DATE AS OF CHANGE: 20240123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gujrathi Sheila CENTRAL INDEX KEY: 0001575202 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40928 FILM NUMBER: 24553287 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ventyx Biosciences, Inc. CENTRAL INDEX KEY: 0001851194 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 832996852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12790 EL CAMINO REAL, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 945-2393 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-21 0 0001851194 Ventyx Biosciences, Inc. VTYX 0001575202 Gujrathi Sheila C/O VENTYX BIOSCIENCES, INC. 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 1 0 0 0 0 Stock Option (Right to Buy) 1.97 2024-01-21 4 A 0 80000 0.00 A 2034-01-21 Common Stock 80000 80000 D The shares subject to the option shall vest on the one-year anniversary of January 21, 2024, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan, the "Plan") through such date, provided that in the event of a Change in Control (as such term is defined in the Plan), one hundred percent (100%) of the then-unvested and outstanding shares subject to the Option will accelerate and fully vest, subject to the reporting person continuing to be a Service Provider through the date of the Change in Control. /s/ Christopher Krueger, as Attorney-in-Fact 2024-01-23